Sector

Financials

138 companies under coverage across 16 industries.

Industries

Browse by industry

Asset Management & Custody Banks 18 Commercial & Residential Mortgage Finance 1 Consumer Finance 6 Diversified Banks 7 Diversified Financial Services 1 Financial Exchanges & Data 10 Insurance Brokers 7 Investment Banking & Brokerage 9 Life & Health Insurance 9 Mortgage REITs 2 Multi-line Insurance 4 Multi-Sector Holdings 3 Property & Casualty Insurance 15 Regional Banks 31 Reinsurance 4 Transaction & Payment Processing Services 11

Coverage

Financials companies

Equity Research

Everest Group Ltd (EG)

BUY. 12-month probability-weighted target $444 (+21% vs spot). Gross Margin explains 52% of Monte Carlo outcome variance.

EGEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +35.9%

Equity Research

Bank Ozk (OZK)

BUY. 12-month probability-weighted target $52 (+17% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

OZKEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +34.7%

Equity Research

Euronet Worldwide Inc (EEFT)

BUY. 12-month probability-weighted target $84 (+30% vs spot). Gross Margin explains 59% of Monte Carlo outcome variance.

EEFTEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +29.3%

Equity Research

First American Corporation (FAF)

HOLD. 12-month probability-weighted target $70 (+15% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

FAFEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +25.1%

Equity Research

Cincinnati Financial Corporation (CINF)

HOLD. 12-month probability-weighted target $183 (+12% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

CINFEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +24.0%

Equity Research

Essent Group Ltd (ESNT)

HOLD. 12-month probability-weighted target $67 (+8% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

ESNTEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +21.2%

Equity Research

MGIC Investment Corp (MTG)

HOLD. 12-month probability-weighted target $29 (+6% vs spot). P/E Multiple explains 90% of Monte Carlo outcome variance.

MTGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +20.9%

Equity Research

Western Alliance Bancorporation (WAL)

HOLD. 12-month probability-weighted target $80 (+7% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

WALEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +20.6%

Equity Research

Zions Bancorporation (ZION)

HOLD. 12-month probability-weighted target $70 (+12% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

ZIONEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +20.2%

Equity Research

Old Republic International Corp (ORI)

HOLD. 12-month probability-weighted target $41 (+6% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

ORIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +19.7%

Equity Research

Primerica Inc (PRI)

HOLD. 12-month probability-weighted target $298 (+8% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

PRIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +17.4%

Equity Research

Stifel Financial Corporation (SF)

HOLD. 12-month probability-weighted target $77 (+10% vs spot). P/E Multiple explains 90% of Monte Carlo outcome variance.

SFEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +17.3%

Equity Research

Evercore Partners Inc (EVR)

BUY. 12-month probability-weighted target $314 (+15% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

EVREquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +17.0%

Equity Research

Jefferies Financial Group Inc (JEF)

BUY. 12-month probability-weighted target $54 (+21% vs spot). P/E Multiple explains 56% of Monte Carlo outcome variance.

JEFEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +16.8%

Equity Research

The Hanover Insurance Group Inc (THG)

HOLD. 12-month probability-weighted target $221 (+1% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

THGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +16.3%

Equity Research

T. Rowe Price Group Inc (TROW)

HOLD. 12-month probability-weighted target $110 (+4% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

TROWEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +15.5%

Equity Research

Globe Life Inc (GL)

HOLD. 12-month probability-weighted target $173 (+6% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

GLEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +14.5%

Equity Research

Hartford Financial Services Group (HIG)

HOLD. 12-month probability-weighted target $135 (+5% vs spot). Gross Margin explains 52% of Monte Carlo outcome variance.

HIGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +14.1%

Equity Research

International Bancshares Corporation (IBOC)

HOLD. 12-month probability-weighted target $77 (+13% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

IBOCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +13.8%

Equity Research

Ally Financial Inc (ALLY)

BUY. 12-month probability-weighted target $46 (+22% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

ALLYEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +13.4%

Equity Research

Selective Insurance Group, Inc. (SIGI)

BUY. 12-month probability-weighted target $96 (+14% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

SIGIEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +11.1%

Equity Research

Raymond James Financial Inc. (RJF)

HOLD. 12-month probability-weighted target $152 (-4% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

RJFEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +11.1%

Equity Research

Fidelity National Financial Inc (FNF)

BUY. 12-month probability-weighted target $51 (+31% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.

FNFEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +11.0%

Equity Research

Progressive Corp (PGR)

HOLD. 12-month probability-weighted target $212 (-2% vs spot). Gross Margin explains 52% of Monte Carlo outcome variance.

PGREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +10.2%

Equity Research

American Express Company (AXP)

HOLD. 12-month probability-weighted target $343 (+11% vs spot). P/E Multiple explains 66% of Monte Carlo outcome variance.

AXPEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +8.9%

Equity Research

SLM Corp (SLM)

HOLD. 12-month probability-weighted target $25 (+10% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

SLMEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +8.3%

Equity Research

Columbia Banking System Inc (COLB)

BUY. 12-month probability-weighted target $33 (+17% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

COLBEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +7.9%

Equity Research

Aon PLC (AON)

BUY. 12-month probability-weighted target $320 (+17% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

AONEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +7.7%

Equity Research

Glacier Bancorp Inc (GBCI)

BUY. 12-month probability-weighted target $53 (+24% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

GBCIEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +7.1%

Equity Research

Starwood Property Trust Inc (STWD)

BUY. 12-month probability-weighted target $17 (+32% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

STWDEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +6.7%

Equity Research

Houlihan Lokey Inc (HLI)

HOLD. 12-month probability-weighted target $139 (+7% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

HLIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.9%

Equity Research

UMB Financial Corporation (UMBF)

HOLD. 12-month probability-weighted target $145 (+11% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

UMBFEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.8%

Equity Research

Erie Indemnity Company (ERIE)

HOLD. 12-month probability-weighted target $241 (+8% vs spot). P/E Multiple explains 54% of Monte Carlo outcome variance.

ERIEEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.8%

Equity Research

RLI Corp (RLI)

HOLD. 12-month probability-weighted target $62 (+11% vs spot). P/E Multiple explains 50% of Monte Carlo outcome variance.

RLIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.5%

Equity Research

Regions Financial Corporation (RF)

HOLD. 12-month probability-weighted target $31 (+13% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

RFEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.5%

Equity Research

Associated Banc-Corp (ASB)

HOLD. 12-month probability-weighted target $30 (+3% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

ASBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.2%

Equity Research

East West Bancorp Inc (EWBC)

HOLD. 12-month probability-weighted target $138 (+10% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

EWBCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.0%

Equity Research

Block, Inc (XYZ)

HOLD. 12-month probability-weighted target $77 (+0% vs spot). Gross Margin explains 59% of Monte Carlo outcome variance.

XYZEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +4.7%

Equity Research

Synchrony Financial (SYF)

HOLD. 12-month probability-weighted target $75 (+3% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

SYFEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +4.3%

Equity Research

Carlyle Group Inc (CG)

HOLD. 12-month probability-weighted target $43 (+11% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

CGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +4.3%

Equity Research

Shift4 Payments Inc (FOUR)

BUY. 12-month probability-weighted target $51 (+28% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

FOUREquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +4.0%

Equity Research

Berkshire Hathaway (BRK-B)

HOLD. 12-month probability-weighted target $513 (-1% vs spot). Gross Margin explains 68% of Monte Carlo outcome variance.

BRK-BEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +3.0%

Equity Research

F.N.B. Corp (FNB)

HOLD. 12-month probability-weighted target $19 (+9% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

FNBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +2.8%

Equity Research

Apollo Global Management LLC Class A (APO)

HOLD. 12-month probability-weighted target $112 (-6% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

APOEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +2.7%

Equity Research

First Horizon Corporation (FHN)

HOLD. 12-month probability-weighted target $26 (+11% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

FHNEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +2.5%

Equity Research

Wintrust Financial Corporation (WTFC)

HOLD. 12-month probability-weighted target $157 (+9% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

WTFCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +2.3%

Equity Research

Kinsale Capital Group Inc (KNSL)

HOLD. 12-month probability-weighted target $354 (+5% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

KNSLEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +2.1%

Equity Research

KeyCorp (KEY)

BUY. 12-month probability-weighted target $24 (+22% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

KEYEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +2.1%

Equity Research

Federated Investors Inc B (FHI)

HOLD. 12-month probability-weighted target $55 (-3% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

FHIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +2.0%

Equity Research

SouthState Corporation (SSB)

HOLD. 12-month probability-weighted target $104 (+4% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

SSBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +1.8%

Equity Research

Aflac Incorporated (AFL)

HOLD. 12-month probability-weighted target $122 (+6% vs spot). P/E Multiple explains 64% of Monte Carlo outcome variance.

AFLEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +1.1%

Equity Research

Pinnacle Financial Partners, Inc. (PNFP)

HOLD. 12-month probability-weighted target $102 (+8% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

PNFPEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.2%

Equity Research

Commerce Bancshares Inc (CBSH)

HOLD. 12-month probability-weighted target $60 (+10% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

CBSHEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.3%

Equity Research

Old National Bancorp (ONB)

HOLD. 12-month probability-weighted target $26 (+6% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

ONBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.4%

Equity Research

Arch Capital Group Ltd. (ACGL)

HOLD. 12-month probability-weighted target $96 (+0% vs spot). P/E Multiple explains 57% of Monte Carlo outcome variance.

ACGLEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.4%

Equity Research

U.S. Bancorp (USB)

HOLD. 12-month probability-weighted target $59 (+4% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

USBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.6%

Equity Research

Charles Schwab Corp (SCHW)

HOLD. 12-month probability-weighted target $90 (-7% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

SCHWEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.7%

Equity Research

Chubb Ltd (CB)

HOLD. 12-month probability-weighted target $329 (-3% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

CBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.7%

Equity Research

Assurant, Inc. (AIZ)

HOLD. 12-month probability-weighted target $255 (-4% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

AIZEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.8%

Equity Research

PNC Financial Services Group Inc (PNC)

HOLD. 12-month probability-weighted target $237 (+8% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

PNCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.9%

Equity Research

Valley National Bancorp (VLY)

HOLD. 12-month probability-weighted target $14 (+11% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

VLYEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -1.0%

Equity Research

Truist Financial Corp (TFC)

HOLD. 12-month probability-weighted target $50 (+8% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

TFCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -1.1%

Equity Research

Texas Capital Bancshares, Inc. (TCBI)

HOLD. 12-month probability-weighted target $103 (+14% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

TCBIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -1.1%

Equity Research

Home BancShares Inc (HOMB)

HOLD. 12-month probability-weighted target $30 (+7% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

HOMBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -1.1%

Equity Research

The Allstate Corporation (ALL)

HOLD. 12-month probability-weighted target $230 (+0% vs spot). Gross Margin explains 48% of Monte Carlo outcome variance.

ALLEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -1.6%

Equity Research

Huntington Bancshares Incorporated (HBAN)

HOLD. 12-month probability-weighted target $18 (+14% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

HBANEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -2.0%

Equity Research

M&T Bank Corporation (MTB)

HOLD. 12-month probability-weighted target $247 (+13% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

MTBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -2.2%

Equity Research

Ameriprise Financial Inc (AMP)

SELL. 12-month probability-weighted target $417 (-17% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

AMPEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -2.5%

Equity Research

American Financial Group, Inc. (AFG)

HOLD. 12-month probability-weighted target $134 (-5% vs spot). Gross Margin explains 48% of Monte Carlo outcome variance.

AFGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -2.8%

Equity Research

Hamilton Lane Inc (HLNE)

HOLD. 12-month probability-weighted target $82 (-4% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

HLNEEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -3.4%

Equity Research

Prudential Financial, Inc. (PRU)

SELL. 12-month probability-weighted target $103 (-9% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

PRUEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -4.0%

Equity Research

Interactive Brokers Group Inc (IBKR)

HOLD. 12-month probability-weighted target $85 (-4% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

IBKREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -4.4%

Equity Research

Cullen/Frost Bankers Inc (CFR)

HOLD. 12-month probability-weighted target $165 (+10% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

CFREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -4.6%

Equity Research

W. R. Berkley Corp (WRB)

HOLD. 12-month probability-weighted target $68 (-6% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

WRBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -5.5%

Equity Research

S&P Global Inc (SPGI)

HOLD. 12-month probability-weighted target $391 (-4% vs spot). P/E Multiple explains 85% of Monte Carlo outcome variance.

SPGIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -6.2%

Equity Research

Capital One Financial Corporation (COF)

HOLD. 12-month probability-weighted target $195 (-2% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

COFEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -6.4%

Equity Research

Wells Fargo & Company (WFC)

HOLD. 12-month probability-weighted target $83 (+0% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

WFCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -7.0%

Equity Research

Bank of America Corp (BAC)

HOLD. 12-month probability-weighted target $57 (+5% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

BACEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -7.2%

Equity Research

Jack Henry & Associates Inc (JKHY)

SELL. 12-month probability-weighted target $130 (-13% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

JKHYEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -7.8%

Equity Research

Renaissancere Holdings Ltd (RNR)

HOLD. 12-month probability-weighted target $301 (-9% vs spot). P/E Multiple explains 57% of Monte Carlo outcome variance.

RNREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -8.0%

Equity Research

Ryan Specialty Group Holdings Inc (RYAN)

HOLD. 12-month probability-weighted target $41 (+10% vs spot). P/E Multiple explains 63% of Monte Carlo outcome variance.

RYANEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -8.1%

Equity Research

Citigroup Inc. (C)

HOLD. 12-month probability-weighted target $144 (+11% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

CEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -8.1%

Equity Research

United Bankshares Inc (UBSI)

HOLD. 12-month probability-weighted target $48 (+5% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

UBSIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -8.6%

Equity Research

First Financial Bankshares Inc (FFIN)

HOLD. 12-month probability-weighted target $35 (+13% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

FFINEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -8.6%

Equity Research

PayPal Holdings Inc (PYPL)

SELL. 12-month probability-weighted target $44 (-21% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

PYPLEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -9.1%

Equity Research

Northern Trust Corporation (NTRS)

HOLD. 12-month probability-weighted target $175 (+4% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

NTRSEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -9.5%

Equity Research

SEI Investments Company (SEIC)

HOLD. 12-month probability-weighted target $98 (-6% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

SEICEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -9.7%

Equity Research

Brown & Brown Inc (BRO)

HOLD. 12-month probability-weighted target $62 (-2% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

BROEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -10.0%

Equity Research

Hancock Whitney Corp (HWC)

HOLD. 12-month probability-weighted target $77 (+7% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

HWCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -10.1%

Equity Research

Citizens Financial Group, Inc. (CFG)

HOLD. 12-month probability-weighted target $71 (+12% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

CFGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -10.1%

Equity Research

Principal Financial Group Inc (PFG)

HOLD. 12-month probability-weighted target $105 (-2% vs spot). P/E Multiple explains 48% of Monte Carlo outcome variance.

PFGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -10.4%

Equity Research

Goldman Sachs Group Inc (GS)

HOLD. 12-month probability-weighted target $993 (+11% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

GSEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -10.4%

Equity Research

Moodys Corporation (MCO)

HOLD. 12-month probability-weighted target $450 (-3% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

MCOEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -10.5%

Equity Research

JPMorgan Chase & Co. (JPM)

SELL. 12-month probability-weighted target $294 (-12% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

JPMEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -10.6%

Equity Research

Blackstone Group Inc (BX)

HOLD. 12-month probability-weighted target $112 (-2% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

BXEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -10.6%

Equity Research

Reinsurance Group of America (RGA)

HOLD. 12-month probability-weighted target $235 (-8% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

RGAEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -11.3%

Equity Research

Voya Financial Inc (VOYA)

HOLD. 12-month probability-weighted target $99 (+4% vs spot). Gross Margin explains 59% of Monte Carlo outcome variance.

VOYAEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -11.8%

Equity Research

Prosperity Bancshares Inc (PB)

HOLD. 12-month probability-weighted target $70 (+6% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

PBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -11.9%

Equity Research

Franklin Resources Inc (BEN)

HOLD. 12-month probability-weighted target $32 (+1% vs spot). P/E Multiple explains 64% of Monte Carlo outcome variance.

BENEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -12.5%

Equity Research

The Travelers Companies Inc (TRV)

SELL. 12-month probability-weighted target $313 (-15% vs spot). P/E Multiple explains 52% of Monte Carlo outcome variance.

TRVEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -12.6%

Equity Research

Morgan Stanley (MS)

HOLD. 12-month probability-weighted target $201 (+6% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

MSEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -12.8%

Equity Research

Fidelity National Information Services Inc (FIS)

HOLD. 12-month probability-weighted target $38 (+10% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

FISEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -12.9%

Equity Research

Marsh & McLennan Companies, Inc. (MRSH)

HOLD. 12-month probability-weighted target $170 (-3% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

MRSHEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -13.4%

Equity Research

Willis Towers Watson PLC (WTW)

HOLD. 12-month probability-weighted target $267 (-10% vs spot). P/E Multiple explains 63% of Monte Carlo outcome variance.

WTWEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -13.7%

Equity Research

Affiliated Managers Group, Inc. (AMG)

HOLD. 12-month probability-weighted target $363 (-6% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

AMGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -14.0%

Equity Research

Arthur J Gallagher & Co (AJG)

HOLD. 12-month probability-weighted target $216 (-7% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

AJGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -15.2%

Equity Research

American International Group Inc (AIG)

HOLD. 12-month probability-weighted target $71 (-8% vs spot). P/E Multiple explains 56% of Monte Carlo outcome variance.

AIGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -15.4%

Equity Research

MSCI Inc (MSCI)

HOLD. 12-month probability-weighted target $542 (-4% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

MSCIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -15.6%

Equity Research

The Bank of New York Mellon Corporation (BNY)

HOLD. 12-month probability-weighted target $141 (-1% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

BNYEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -16.0%

Equity Research

State Street Corp (STT)

HOLD. 12-month probability-weighted target $168 (-4% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

STTEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -16.6%

Equity Research

Morningstar Inc (MORN)

SELL. 12-month probability-weighted target $170 (-17% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

MORNEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -16.7%

Equity Research

KKR & Co. Inc. (KKR)

HOLD. 12-month probability-weighted target $87 (-5% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

KKREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -17.2%

Equity Research

FactSet Research Systems Inc (FDS)

SELL. 12-month probability-weighted target $232 (-19% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

FDSEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -17.4%

Equity Research

Global Payments Inc (GPN)

SELL. 12-month probability-weighted target $69 (-16% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

GPNEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -18.2%

Equity Research

BlackRock Inc (BLK)

SELL. 12-month probability-weighted target $912 (-16% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

BLKEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -18.6%

Equity Research

Fifth Third Bancorp (FITB)

HOLD. 12-month probability-weighted target $51 (+1% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

FITBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -19.0%

Equity Research

Cboe Global Markets Inc (CBOE)

SELL. 12-month probability-weighted target $232 (-24% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

CBOEEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -19.2%

Equity Research

Mastercard Inc (MA)

SELL. 12-month probability-weighted target $491 (-17% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

MAEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -20.7%

Equity Research

Invesco Plc (IVZ)

SELL. 12-month probability-weighted target $26 (-12% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

IVZEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -20.8%

Equity Research

MetLife Inc (MET)

SELL. 12-month probability-weighted target $82 (-16% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

METEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -21.0%

Equity Research

Nasdaq Inc (NDAQ)

SELL. 12-month probability-weighted target $80 (-14% vs spot). P/E Multiple explains 95% of Monte Carlo outcome variance.

NDAQEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -21.9%

Equity Research

Wex Inc (WEX)

HOLD. 12-month probability-weighted target $157 (-9% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

WEXEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -22.1%

Equity Research

Unum Group (UNM)

HOLD. 12-month probability-weighted target $85 (-7% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.

UNMEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -22.1%

Equity Research

Corpay Inc (CPAY)

SELL. 12-month probability-weighted target $338 (-15% vs spot). P/E Multiple explains 85% of Monte Carlo outcome variance.

CPAYEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -22.4%

Equity Research

CNO Financial Group Inc (CNO)

HOLD. 12-month probability-weighted target $51 (-3% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.

CNOEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -22.5%

Equity Research

FirstCash Inc (FCFS)

HOLD. 12-month probability-weighted target $214 (+0% vs spot). P/E Multiple explains 48% of Monte Carlo outcome variance.

FCFSEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -22.9%

Equity Research

Intercontinental Exchange Inc (ICE)

SELL. 12-month probability-weighted target $121 (-23% vs spot). P/E Multiple explains 95% of Monte Carlo outcome variance.

ICEEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -24.5%

Equity Research

Ares Management LP (ARES)

SELL. 12-month probability-weighted target $102 (-13% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

ARESEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -26.1%

Equity Research

CME Group Inc (CME)

SELL. 12-month probability-weighted target $214 (-24% vs spot). P/E Multiple explains 95% of Monte Carlo outcome variance.

CMEEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -26.9%

Equity Research

Robinhood Markets (HOOD)

SELL. 12-month probability-weighted target $80 (-27% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

HOODEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -40.0%

Equity Research

Flagstar Financial, Inc. (FLG)

SELL. 12-month probability-weighted target $7 (-39% vs spot). P/E Multiple explains 85% of Monte Carlo outcome variance.

FLGEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -47.9%

Equity Research

Coinbase Global Inc (COIN)

SELL. 12-month probability-weighted target $114 (-37% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

COINEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -48.6%

Equity Research

Visa Inc. Class A (V)

Rating suspended since 2026-10-02 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

VEquity ResearchMonte Carlo

10 October 2026Rating: N/A

Equity Research

Axa Equitable Holdings Inc (EQH)

Rating suspended since 2026-09-29 — valuation method under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

EQHEquity ResearchMonte Carlo

10 October 2026Rating: N/A

Equity Research

Corebridge Financial Inc. (CRBG)

CRBGEquity ResearchMonte Carlo

10 October 2026Rating: N/A

Equity Research

Annaly Capital Management, Inc. (NLY)

Rating suspended since 2026-10-01 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

NLYEquity ResearchMonte Carlo

1 October 2026Rating: N/A

Equity Research

Loews Corp (L)

Rating suspended since 2026-09-19 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

LEquity ResearchMonte Carlo

19 September 2026Rating: N/A

Equity Research

Brighthouse Financial, Inc. (BHF)

Rating suspended since 2026-10-03 — valuation method under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

BHFEquity ResearchMonte Carlo

16 September 2026Rating: N/A